Oxprenoate potassium
Appearance
![]() | |
Clinical data | |
---|---|
Other names | RU-28318; 17α-Hydroxy-3-oxo-7α-propylpregn-4-ene-21-carboxylic acid monopotassium salt |
Drug class | Antimineralocorticoid |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C25H37KO4 |
Molar mass | 440.665 g·mol−1 |
3D model (JSmol) | |
| |
|
Oxprenoate potassium (developmental code name RU-28318) is a synthetic steroidal antimineralocorticoid which was never marketed.[1] The affinities of oxprenoate potassium for the steroid hormone receptors have been reported.[2]
See also
References
- ^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 922–. ISBN 978-1-4757-2085-3.
- ^ Raynaud JP; Fortin M; Hunt P; Ojasoo T; Doré JC; Surcouf E; Mornon JP (1986). "Approaches to drug development using receptors". In Antonio M. Gotto; Bert W. O'Malley; Fondation Princesse Liliane (eds.). The Role of Receptors in Biology and Medicine: Proceedings of the Ninth Argenteuil Symposium. Raven Press. pp. 65–77. ISBN 978-0-88167-161-2.